16 results on '"Navaglia, F."'
Search Results
2. Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study.
- Author
-
Basso D, Aita A, Padoan A, Cosma C, Navaglia F, Moz S, Contran N, Zambon CF, Maria Cattelan A, and Plebani M
- Subjects
- Humans, Luminescent Measurements, Nasopharynx virology, Pandemics, Point-of-Care Testing, Prospective Studies, SARS-CoV-2, Sensitivity and Specificity, Antigens, Viral analysis, COVID-19 diagnosis, Saliva chemistry
- Abstract
Background and Aim: SARS-CoV-2 quick testing is relevant for the containment of new pandemic waves. Antigen testing in self-collected saliva might be useful. We compared salivary and naso-pharyngeal swab (NPS) SARS-CoV-2 antigen detection by a rapid chemiluminescent assay (CLEIA) and two different point-of-care (POC) immunochromatographic assays, with results of molecular testing., Methods: 234 patients were prospectively enrolled. Paired self-collected saliva (Salivette) and NPS were obtained to perform rRT-PCR, chemiluminescent (Lumipulse G) and POC (NPS: Fujirebio and Abbott; saliva: Fujirebio) for SARS-CoV-2 antigen detection., Results: The overall agreement between NPS and saliva rRT-PCR was 78.7%, reaching 91.7% at the first week from symptoms. SARS-CoV-2 CLEIA antigen was highly accurate in distinguishing positive and negative NPS (ROC-AUC = 0.939, 95%CI:0.903-0.977), with 81.6% sensitivity and 93.8% specificity. This assay on saliva reached the optimal value within 7 days from symptoms onset (Sensitivity: 72%; Specificity: 97%). Saliva POC antigen was limited in sensitivity (13%), performing better in NPS (Sensitivity: 48% and 66%; Specificity: 100% and 99% for Espline and Abbott respectively), depending on viral loads., Conclusions: Self-collected saliva is a valid alternative to NPS for SARS-CoV-2 detection by molecular, but also by CLEIA antigen testing, which is therefore potentially useful for large scale screening., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
3. SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis.
- Author
-
Aita A, Basso D, Cattelan AM, Fioretto P, Navaglia F, Barbaro F, Stoppa A, Coccorullo E, Farella A, Socal A, Vettor R, and Plebani M
- Subjects
- Adult, Aged, Aged, 80 and over, COVID-19 Testing, Coronavirus Infections diagnosis, Female, Humans, Immunoglobulin A immunology, Male, Middle Aged, Reference Standards, SARS-CoV-2, Betacoronavirus immunology, Clinical Laboratory Techniques, Immunoglobulin A analysis, Saliva chemistry, Specimen Handling standards
- Abstract
Aim: This study aims to verify whether standardized saliva collection is suitable for SARS-CoV-2 molecular detection and IgA measurement., Methods: 43 COVID-19 inpatients and 326 screening subjects underwent naso-pharyngeal (NP)-swab and saliva collection (Salivette). Inpatients also underwent repeated blood collections to evaluate inflammation and organs involvement. In all patients and subjects, SARS-CoV-2 (gene E) rRT-PCR was undertaken in saliva and NP-swabs. Salivary IgA and serum IgA, IgG, IgM were measured on inpatients' samples., Results: NP-swabs and saliva were both SARS-CoV-2 positive in 7 (16%) or both negative in 35 (82%) out of 43 patients successfully included in the study. NP-swabs and saliva results did not perfectly match in one patient (saliva positive, NP-swab negative). Positive molecular results were significantly associated with disease duration (p = 0.0049). 326/326 screening subjects were SARS-CoV-2 negative on both NP-swabs and saliva. Among the 27 saliva samples tested for IgA, 18 were IgA positive. Salivary IgA positivity was associated with pneumonia (p = 0.002) and CRP values (p = 0.0183), not with other clinical and molecular data, or with serum immunoglubulins., Conclusions: A standardized saliva collection can be adopted to detect SARS-CoV-2 infection in alternative to NP-swabs. Preliminary data on salivary IgA support the use of saliva also for patient monitoring., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
4. Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study.
- Author
-
Bedogni A, Bettini G, Bedogni G, Basso D, Gatti D, Valisena S, Brunello A, Sorio M, Berno T, Giannini S, Navaglia F, Plebani M, Nocini PF, Blandamura S, Saia G, and Bertoldo F
- Subjects
- Case-Control Studies, Diphosphonates, Humans, Neoplasms, Risk Factors, Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agents adverse effects, Vitamin D Deficiency drug therapy
- Abstract
Purpose: A previous case-control histomorphometric study showed higher odds of osteomalacia in patients with bisphosphonate-related osteonecrosis of the jaw (BRONJ). Vitamin D deficiency causes osteomalacia and may therefore be involved in the pathogenesis of BRONJ. The present case-control study aimed at testing such hypothesis., Materials and Methods: BRONJ+ and BRONJ- patients treated with bisphosphonates were matched by sex (same) and age (within 5 years). Serum 25-hydroxy-vitamin D (25-OH-D), parathyroid hormone, bone alkaline phosphatase, total procollagen type 1 amino-terminal propeptide, carboxy-terminal collagen crosslinks, Dickkopf WNT signaling pathway inhibitor 1 and sclerostin were measured., Results: The main outcome was vitamin D deficiency defined as 25-OH-D < 50 nmol/l. A total of 51 BRONJ+ and 73 BRONJ- patients were studied. The frequency (95% CI) of vitamin D deficiency was 59% (45%-72%) in BRONJ+ and 62% (48%-75%) in BRONJ- patients. This amounts to a difference of -3% (-22%-16%, p = 0.77) for BRONJ+ patients. Serum 25-hydroxy-vitamin D and parathyroid hormone were similar in BRONJ+ and BRONJ- patients. Among the bone metabolism markers, only sclerostin differed between the two groups, being higher in BRONJ+ patients., Conclusion: The present matched case-control study suggests that vitamin D deficiency is not a risk factor for BRONJ., (Copyright © 2019 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
5. Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study.
- Author
-
Aita A, Rossi E, Basso D, Guariso G, Bozzato D, Pelloso M, Pescarin M, Zambon CF, Navaglia F, Greco E, Gasparetto M, Fogar P, Padoan A, Moz S, and Plebani M
- Subjects
- Case-Control Studies, Celiac Disease diagnosis, Celiac Disease diet therapy, Celiac Disease immunology, Child, Diet, Gluten-Free, Disease Management, Female, Gliadin blood, Gliadin immunology, Humans, Male, Observer Variation, Reproducibility of Results, Transglutaminases blood, Transglutaminases immunology, Celiac Disease blood, Enzyme-Linked Immunosorbent Assay standards, Immunoglobulin A blood, Immunoglobulin G blood, Luminescent Measurements standards
- Abstract
Background: Anti-transglutaminase (tTG) or anti-deamidated gliadin peptides (DGP) serum determination is the first step in diagnosing celiac disease (CD). Our aims were to: compare the performance of novel chemiluminescent tool in the detection of tTG and DGP (Q-Flash®, Inova) with that of the established ELISA (Q-Lite®, Inova) methods; identify the more reliable index for making a sound diagnosis and monitoring therapy., Methods: Using Q-Flash® and Q-Lite®, IgA and IgG class tTG and DGP were measured in the sera of 155 CD pediatric patients and 166 healthy age-matched controls. Forty-two of the patients had a follow-up one year after starting gluten free diet (GFD)., Results: Q-Flash® IgA tTG, the more accurate (intra-assay CV for low, intermediate and high values: 2.2%, 1.6%, and 1.1%; inter-assay CV: 2.8%, 4%, and 3%), sensitive (96.1%) and specific (97%) test for diagnosing CD, was the only variable to be significantly correlated with CD at binary logistic regression analysis (r=0.263, p<0.0001, Exp(B)=1.0506, 95% CI=1.0286-1.0731). Q-Flash® IgA tTG or DGP screen were more accurate than Q-Lite® IgA tTG in monitoring CD patients on GFD (p=0.003)., Conclusion: Q- Flash® IgA tTG measurement is an extremely precise, sensitive and specific index for not only diagnosing CD, but also monitoring therapy., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
6. New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis.
- Author
-
Basso D, Guariso G, Bozzato D, Rossi E, Pescarin M, Fogar P, Moz S, Navaglia F, Pelloso M, Gasparetto M, Zambon CF, Padoan A, Greco E, Rugge M, and Plebani M
- Subjects
- Adolescent, Case-Control Studies, Child, Child, Preschool, Female, Humans, Infant, Male, Retrospective Studies, Sensitivity and Specificity, Celiac Disease diagnosis, Transglutaminases immunology
- Abstract
Background: The identification of specific serological algorithms allowing the diagnosis of celiac disease (CD) is a new challenge for both the clinic and the laboratory. We compared the diagnostic accuracy of three new tests proposed for CD screening with that of the well established IgA tTG, and ascertained whether any combination of these tools might enhance accuracy in diagnosing CD., Methods: In sera from 329 CD and 374 control children, the following were assayed: IgA tTG; IgA/IgG, which identify tTG-gliadin complexes (Aeskulisa Celi Check and CeliCheck IgGA); IgA/IgG, which identify deamidated gliadin peptides and tTG (QUANTA Lite(TM) h-tTG/DGP Screen)., Results: When specificity was set at 100%, the most sensitive index of CD was IgA tTG (75.7%, cut-off=100U), followed by QUANTA Lite(TM) h-tTG/DGP Screen (65.3%, cut-off 145U), Aeskulisa Celi Check (62.6%, cut-off 909U/mL) and CeliCheck IgGA (59.6%, cut-off 977U/mL). Three algorithms were obtained by combining IgA tTG with each of the new tests. The algorithm obtained by measuring IgA tTG and QUANTA Lite(TM) h-tTG/DGP Screen allowed the correct identification of CD in 78.7% of cases (negative predictive value=97.3%)., Conclusions: The two-test based strategy could be used for the cost effective diagnosis of CD., (Copyright © 2011. Published by Elsevier B.V.)
- Published
- 2011
- Full Text
- View/download PDF
7. GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children.
- Author
-
Guariso G, Basso D, Bortoluzzi CF, Meneghel A, Schiavon S, Fogar P, Farina M, Navaglia F, Greco E, Mescoli C, Zambon CF, and Plebani M
- Subjects
- Adolescent, Celiac Disease diagnosis, Child, Child, Preschool, Endoscopy, Gastrointestinal, Female, Gastric Mucosa microbiology, Gastritis diagnosis, Gastritis microbiology, Gastrointestinal Diseases microbiology, Helicobacter Infections complications, Helicobacter pylori immunology, Humans, Infant, Logistic Models, Male, Sensitivity and Specificity, Antibodies, Bacterial blood, Gastrins blood, Gastrointestinal Diseases diagnosis, Pepsinogen A blood, Pepsinogen C blood
- Abstract
Background: The combined evaluation of serum pepsinogens A (PGA) and C (PGC), gastrin-17 (G17) and anti-H. pylori antibodies (anti-H. pylori)(GastroPanel) has recently been proposed as a useful aid for investigating H. pylori-associated gastric mucosal inflammation. Our aim was to evaluate whether GastroPanel can correctly classify children who need or not endoscopy (EGD)., Methods: GastroPanel was performed in 554 consecutive children subjected to EGD., Results: PGC and anti-H. pylori were sensitive (82.5% and 73.1%) and specific (58.1% and 84.0%) indices of H. pylori infection. Antral H. pylori colonization density, inflammation and activity grades were correlated with PGC. PGC and G17 were significantly higher in children with celiac disease (14.9+/-0.88 microg/L and 5.6+/-0.79 pmol/L) than in controls (8.5+/-0.38 microg/L and 2.4+/-0.24 pmol/L). The best cut-offs to distinguish H. pylori infected children from controls were 7.45 microg/L for PGC, 4.2 pmol/L for G17, 18 U for anti-H. pylori and 25 microg/L for PGA. With these cut-offs, GastroPanel had a NPV of 89.6% and a PPV of 66.8%., Conclusions: A negative GastroPanel result in children with upper abdominal non alarm symptoms, should allow the paediatrician to reasonably rule out the presence of major gastro-duodenal diseases and therefore avoid EGD.
- Published
- 2009
- Full Text
- View/download PDF
8. IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections.
- Author
-
Zambon CF, Basso D, Marchet A, Fasolo M, Stranges A, Schiavon S, Navaglia F, Greco E, Fogar P, Falda A, D'Odorico A, Rugge M, Nitti D, and Plebani M
- Subjects
- Adult, Aged, Female, Helicobacter Infections diagnosis, Humans, Male, Middle Aged, Antigens, Bacterial genetics, Bacterial Proteins genetics, Haplotypes, Helicobacter Infections genetics, Interleukin-4 genetics, Interleukin-4 Receptor alpha Subunit genetics, Polymorphism, Genetic
- Abstract
Background: The Th2 cytokine IL-4 might limit H. pylori associated gastric inflammation and favour H. pylori clearance. The aim of the study was to verify whether IL-4 -588C>T SNP, or two SNPs of the gene coding the alpha chain of IL-4 receptor (IL-4RA Ex5+14A>G, IL-4RA Ex11+828A>G) considered singly or as haplotypes, are correlated with H. pylori virulence genes or H. pylori associated diseases., Methods: We studied 144 patients with non-cardia gastric cancer (NCGC)(41/50 with present or past H. pylori infection), 75 with duodenal ulcer (DU)(66 H. pylori infected) and 171 with gastritis (CG)(107 H. pylori infected). cagA gene was present in 24/28 NCGC, 45/59 DU and 56/107 CG., Results: All SNPs were in Hardy-Weinberg equilibrium. IL-4RA haplotypes frequencies were estimated using Arlequin software. Neither the SNPs nor the IL-4RA haplotype correlated with disease diagnosis, H. pylori infection, degree of mucosal inflammation or intestinal metaplasia. IL-4 -588T allele (OR=3.69, 95% CI:1.34-10.16) and IL-4RA GA haplotype (p<0.05) enhanced the risk for cagA positive infections. IL-4RA GA haplotype correlated with IL-4 protein levels in H. pylori infected gastric mucosa., Conclusions: IL-4 and IL-4RA gene polymorphisms concur in selecting the H. pylori infecting strain, probably influencing the IL-4 signalling pathway.
- Published
- 2008
- Full Text
- View/download PDF
9. DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis.
- Author
-
Basso D, Navaglia F, Fogar P, Zambon CF, Greco E, Schiavon S, Fasolo M, Stranges A, Falda A, Padoan A, Fadi E, Pedrazzoli S, and Plebani M
- Subjects
- Animals, DNA Mismatch Repair, Gastrointestinal Neoplasms pathology, Humans, Pancreatic Neoplasms genetics, Pancreatic Neoplasms pathology, DNA Repair drug effects, DNA, Mitochondrial genetics, Gastrointestinal Neoplasms genetics, Mutation physiology, Signal Transduction drug effects
- Abstract
This work focuses on the main DNA repair pathways, highlighting their role in gastrointestinal carcinogenesis and the role of mitochondrial DNA (mtDNA), mutations being described in several tumor types, including those of the gastrointestinal tract. The mismatch repair (MMR) system is inherently altered in patients with hereditary non-polyposis colorectal cancer, and plays a role in carcinogenesis in a subset of sporadic colorectal, gastric and esophageal cancers. Alterations in homologous recombination (HR) and non-homologous end-joining (NHEJ) also contribute to the development of pancreatic cancer. Gene polymorphisms of some X-ray cross-complementing (XRCCs), cofactor proteins involved in the base excision repair pathway, have been investigated in relation to gastric, colorectal and pancreatic cancer. Yet only one polymorphism, XRCC1 Arg194Trp, appears to be involved in smoking-related cancers and in early onset pancreatic cancer. Although evidence in the literature indicates that mtDNA somatic mutations play a role in gastric and colorectal carcinogenesis, no sound conclusions have yet been drawn regarding this issue in pancreatic cancer, although an mtDNA variant at 16519 is believed to worsen the outcome of pancreatic cancer patients, possibly because it is involved in altering cellular metabolism.
- Published
- 2007
- Full Text
- View/download PDF
10. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?
- Author
-
Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, Giunco S, Valerio A, Navaglia F, Zambon CF, Falda A, Pedrazzoli S, and Plebani M
- Subjects
- Adult, Aged, Aged, 80 and over, Cell Line, Tumor, Female, Humans, Male, Middle Aged, S100 Proteins physiology, Spectrometry, Mass, Electrospray Ionization, Diabetes Mellitus etiology, Pancreatic Neoplasms chemistry, S100 Proteins chemistry
- Abstract
Background: Our aim was to identify the pancreatic cancer diabetogenic peptide., Methods: Pancreatic tumor samples from patients with (n=15) or without (n=7) diabetes were compared with 6 non-neoplastic pancreas samples using SDS-PAGE., Results: A band measuring approximately 1500 Da was detected in tumors from diabetics, but not in neoplastic samples from non-diabetics or samples from non-neoplastic subjects. Sequence analysis revealed a 14 amino acid peptide (1589.88 Da), corresponding to the N-terminal of the S100A8. At 50 nmol/L and 2 mmol/L, this peptide significantly reduced glucose consumption and lactate production by cultured C(2)C(12) myoblasts. The 14 amino acid peptide caused a lack of myotubular differentiation, the presence of polynucleated cells and caspase-3 activation., Conclusions: The 14 amino acid peptide from S100A8 impairs the catabolism of glucose by myoblasts in vitro and may cause hyperglycemia in vivo. Its identification in biological fluids might be helpful in diagnosing pancreatic cancer in patients with recent onset diabetes mellitus.
- Published
- 2006
- Full Text
- View/download PDF
11. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications.
- Author
-
Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, Giunco S, Valerio A, Navaglia F, Zambon CF, Pedrazzoli S, and Plebani M
- Subjects
- Animals, Diabetes Complications diagnosis, Diabetes Complications genetics, Glucose metabolism, Humans, Pancreatic Neoplasms diagnosis, Diabetes Complications etiology, Diabetes Complications metabolism, Pancreatic Neoplasms complications, Pancreatic Neoplasms metabolism, Proteomics
- Abstract
Background: Diabetes mellitus is associated with pancreatic cancer in more than 80% of the cases. Clinical, epidemiological, and experimental data indicate that pancreatic cancer causes diabetes mellitus by releasing soluble mediators which interfere with both beta-cell function and liver and muscle glucose metabolism., Methods: We analysed, by matrix-assisted laser desorption ionization time of flight (MALDI-TOF), a series of pancreatic cancer cell lines conditioned media, pancreatic cancer patients' peripheral and portal sera, comparing them with controls and chronic pancreatitis patients' sera., Results: MALDI-TOF analysis of pancreatic cancer cells conditioned media and patients' sera indicated a low molecular weight peptide to be the putative pancreatic cancer-associated diabetogenic factor. The sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis of tumor samples from diabetic and non-diabetic patients revealed the presence of a 1500 Da peptide only in diabetic patients. The amino acid sequence of this peptide corresponded to the N-terminal of an S-100 calcium binding protein, which was therefore suggested to be the pancreatic cancer-associated diabetogenic factor., Conclusions: We identified a tumor-derived peptide of 14 amino acids sharing a 100% homology with an S-100 calcium binding protein, which is probably the pancreatic cancer-associated diabetogenic factor.
- Published
- 2005
- Full Text
- View/download PDF
12. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
- Author
-
Cillo U, Navaglia F, Vitale A, Molari A, Basso D, Bassanello M, Brolese A, Zanus G, Montin U, D'Amico F, Ciarleglio FA, Carraro A, Bridda A, Burra P, Carraro P, Plebani M, and D'Amico DF
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers, Tumor, Carcinoma, Hepatocellular pathology, Cell Line, Tumor, Colonic Neoplasms blood, DNA Primers, DNA, Neoplasm biosynthesis, DNA, Neoplasm isolation & purification, Electrophoresis, Agar Gel, Female, Humans, Liver Cirrhosis blood, Liver Neoplasms pathology, Male, Middle Aged, Neoplasm Recurrence, Local blood, Pancreatic Neoplasms blood, Prognosis, Prospective Studies, Reverse Transcriptase Polymerase Chain Reaction, Survival Analysis, Carcinoma, Hepatocellular blood, Liver Neoplasms blood, RNA, Messenger blood, alpha-Fetoproteins biosynthesis
- Abstract
Background: Alpha-fetoprotein (AFP) messenger RNA (mRNA) in the blood reflects the presence of circulating hepatocellular carcinoma (HCC) cells and is a sensitive marker of HCC extrahepatic metastases. The specificity of this molecular marker and its correlation with the main HCC clinical-pathological parameters remains controversial, however., Methods: AFPmRNA was determined in 50 HCC patients and in 50 patients with diagnosis of cirrhosis (6), or colon (24) or, pancreatic (20) carcinoma. HCC patients with clinically evident extrahepatic metastasis were excluded. HCC diagnosis was confirmed in all patients by histology on percutaneous biopsies or surgical specimens; pathological grading was assessed at the same time., Results: AFPmRNA was positive in 20 HCC patients (40%) and in 18 patients without HCC (36%). The presence of AFPmRNA in the blood correlated significantly with cholestatic indices (p<0.01), nodule size (p=0.03), vascular invasion (p=0.006) and moderately or poorly differentiated HCC (p<0.0001). Moreover, survival analysis showed a significant impact of AFPmRNA detection on overall (p=0.04) and recurrence-free survival (p=0.0007) after a median follow-up of 17 months., Conclusions: Although AFPmRNA is frequently detected in the blood, even in benign liver diseases or gastroenteric tumors, in HCC patients without clinical evidence of extrahepatic metastases it seemed to identify the biologically more aggressive tumors.
- Published
- 2004
- Full Text
- View/download PDF
13. Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides.
- Author
-
Valerio A, Basso D, Fogar P, Falconi M, Greco E, Bassi C, Seraglia R, Abu-Hilal M, Navaglia F, Zambon CF, Gallo N, Falda A, Pedrazzoli S, and Plebani M
- Subjects
- Aged, Aged, 80 and over, Biomarkers analysis, Cell Line, Tumor, Cells, Cultured, Diabetes Complications genetics, Diabetes Complications metabolism, Female, Glyceraldehyde-3-Phosphate Dehydrogenases genetics, Glyceraldehyde-3-Phosphate Dehydrogenases metabolism, Humans, Liver enzymology, Liver metabolism, Male, Middle Aged, Nitrites analysis, Pancreatic Neoplasms genetics, Pancreatic Neoplasms metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Diabetes Complications blood, Pancreatic Neoplasms blood, Pancreatic Neoplasms complications
- Abstract
Background: Pancreatic cancer (PC) associated diabetes mellitus (DM) might be consequent to the diabetogenic effects of tumour products, possibly acting via nitric oxide (NO). Our aims were: (1) to verify whether PC associated DM determines an increased hepatic NO and (2) using MALDI-TOF analysis, to evaluate the peptide composition of PC cell conditioned media (CM) and of portal sera from patients with PC with (n=7) or without (n=4) DM., Methods: In liver tissue homogenates of 23 patients with PC (n=17) or chronic pancreatitis (n=6) GAPDH mRNA and activity, glucose, lactate, nitrite and nitrate were assayed. MALDI-TOF analysis was performed in three PC cell lines CM, and in portal sera from patients with PC., Results: Higher GAPDH mRNA and nitrite were found in patients with than in patients without DM. In PC cell CM, only 9 among a total of 75 fragments identified, were tumour specific. One hundred seventy-three fragments were identified in the portal sera of patients: one was positively and six fragments were negatively correlated with DM., Conclusions: Unlike liver GAPDH, NO appears to be involved in PC associated DM. In portal sera, the absence, rather than the presence, of specific fragments, appears to be correlated with the development of DM.
- Published
- 2004
- Full Text
- View/download PDF
14. Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model.
- Author
-
Fogar P, Greco E, Basso D, Habeler W, Navaglia F, Zambon CF, Tormen D, Gallo N, Cecchetto A, Plebani M, and Pedrazzoli S
- Subjects
- Animals, Antiviral Agents therapeutic use, Female, Ganciclovir therapeutic use, Injections, Intraperitoneal, Mice, Mice, SCID, Pancreatic Neoplasms pathology, Random Allocation, Retroviridae genetics, Reverse Transcriptase Polymerase Chain Reaction, Simplexvirus enzymology, Splenic Neoplasms secondary, Tumor Cells, Cultured, Xenograft Model Antitumor Assays, Genetic Therapy, Pancreatic Neoplasms therapy, Thymidine Kinase genetics
- Abstract
Aim: To study in vivo whether pancreatic cancer tumour growth and metastasis can be modified by a gene construct with HSV-TK suicide gene and IL2 co-expression., Methods: Seventy-eight female SCID mice were i.p. inoculated with retrovirally transduced or control MIA PaCa 2, CAPAN-1 and PANC-1 cell lines. The animals were then randomly selected for saline or ganciclovir (GCV) treatment from the second week, for a total of two weeks., Results: Most inoculated mice developed tumour nodules and spleen metastases. The liver was colonized by control CAPAN-1 and MIA PaCa 2, but not by PANC-1. Tumours in transduced MIA PaCa 2 cell injected mice were smaller, and in transduced CAPAN-1 injected mice larger, than in control-inoculated mice. There were increased pancreatic and decreased spleen metastases from transduced CAPAN-1, and diminished liver involvement from transduced MIA PaCa 2. No differences were found between mice inoculated with transduced and control PANC-1 cell lines. GCV treatment had no effect on tumour's size or metastases., Conclusions: The HSV-TK suicide gene does not confer GCV sensitivity to pancreatic cancer in this in vivo model. Different pancreatic cancer cell lines cause different growth and metastasis patterns after inoculation in SCID mice, possibly because of variations in their inherent characteristics. The different effects of our vector on cell growth and metastasis may be attributable to the effects of the immunostimulatory cytokine IL2.
- Published
- 2003
- Full Text
- View/download PDF
15. ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications.
- Author
-
Zambon C, Navaglia F, Basso D, Gallo N, Greco E, Piva MG, Fogar P, Pasquali C, Pedrazzoli S, and Plebani M
- Subjects
- Adult, Aged, Aged, 80 and over, Codon, DNA blood, DNA Mutational Analysis methods, Electrophoresis, Agar Gel, Female, Humans, Male, Middle Aged, Point Mutation, Tumor Cells, Cultured, Bile chemistry, DNA analysis, Genes, ras, Mutation, Pancreatic Neoplasms genetics, Polymerase Chain Reaction methods
- Abstract
Our aim was to assess the clinical reliability of mutated K-ras detection in serum or bile for the diagnosis of pancreatic cancer using ME-PCR. DNA was extracted from 1 ml serum obtained from 29 patients with pancreatic cancer and 12 control subjects. ME-PCR was optimized using a mixture of normal DNA added with different amounts of mutated DNA. The analysis of sera obtained from the 29 patients and of bile obtained from 11 pancreatic cancer patients demonstrated the presence of mutated K-ras in two (6.9%) and four cases (36%). By contrast K-ras was not amplifiable in any of the 12 serum samples obtained from healthy controls. In conclusion the DNA obtained from pancreatic cancer patients' sera is suitable for K-ras amplification and for the identification of codon 12 point mutations. However ME-PCR alone has an unsatisfactory sensitivity for the detection of pancreatic cancer using serum DNA as starting template.
- Published
- 2000
- Full Text
- View/download PDF
16. Touchdown PCR: a rapid method to genotype Helicobacter pylori infection.
- Author
-
Navaglia F, Basso D, and Plebani M
- Subjects
- Genotype, Humans, Helicobacter Infections genetics, Helicobacter pylori genetics, Polymerase Chain Reaction methods
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.